Status:
COMPLETED
Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
Bristol-Myers Squibb
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether treatment with a fixed dose combination dapagliflozin/metformin tablet is affected by food.
Eligibility Criteria
Inclusion
- Healthy
- BMI 18-30 kg/m2
Exclusion
- History of clinically significant illness.
- History of alcohol or drug abuse
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01156246
Start Date
June 1 2010
End Date
August 1 2010
Last Update
June 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Luleå, Sweden